EUVIMEDEUVIMED entdecken
Open Access

Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross‐Sectional Study of Patient‐ and Joint‐Level Analyses Using Musculoskeletal Ultrasound

Takeo Abe iD, Yusuke Inagaki, Chie Ogita, Yuko Minagawa, Taduko Tokugawa, Akihiro Sawada, Satoshi Higasa, Yoshitoshi Ohtsuka, Teppei Hashimoto, Naoto Azuma

Haemophilia · 2026

DOI: 10.1111/hae.70345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haemophilia, 2026. Verfasst von Takeo Abe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan. Hauptthemen laut MEDLINE: Hemophilia A, Synovial Membrane, Joint Diseases, Hemarthrosis. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Chugai Pharmaceutical Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Early identification of synovial hypertrophy is critical for preventing irreversible changes in haemophilic arthropathy (HA). Although prophylaxis has improved joint outcomes, it remains unclear which patients and joints in early HA should be prioritised for musculoskeletal ultrasound (MSKUS) screening.

Aim

To identify the predictors of synovial hypertrophy at the patient and joint levels in early HA.

Methods

We enrolled patients with haemophilia aged 6–49 years with mild joint damage (Arnold–Hilgartner grades I–III). Elbows, knees and ankles were examined using MSKUS. Patient‐level factors included age, body mass index, haemophilia characteristics, adherence and activity. Joint‐level factors included symptoms, recent bleeding, physical findings and radiographic scores. Logistic regression was applied to patient‐level predictors and mixed‐effects models to joint‐level predictors.

Results

In total, 203 joints from 40 patients were evaluated; synovial hypertrophy was identified in 82 joints (34 patients), most frequently in the knees (54.5%), followed by the elbows (38.9%) and ankles (22.2%). Adult age was the only significant patient‐level predictor of synovial hypertrophy (odds ratio, 5.2; p = 0.001). At the joint level, no examined factors were significantly associated with synovial hypertrophy. Among asymptomatic joints, 37.9% demonstrated synovial hypertrophy (23.7% in paediatric patients vs. 56.9% in adults), with elbow involvement showing no significant age‐related differences (34.4% vs. 40.7%, p = 0.79).

Conclusions

Patient‐ and joint‐specific findings alone are insufficient to predict synovial hypertrophy. MSKUS may be used routinely to enhance early detection in patients with HA on prophylaxis. Elbow synovial hypertrophy warrants attention from paediatric patients as one of the earliest stages of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia ASynovial MembraneJoint DiseasesHemarthrosisHumansChildCross-Sectional StudiesMaleHypertrophyAdolescentAdultMiddle AgedUltrasonographyYoung AdultFemaleJoints

Stichwörter der Autor:innen

HEAD‐USasymptomatic synovial hypertrophyhaemophilic arthropathymusculoskeletal ultrasoundprophylaxis

Autor:innen und Institutionen

  • Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
  • Department of Rehabilitation Medicine, Nara Medical University, Kashihara, Nara, Japan.
  • Department of Respiratory Medicine and Haematology, School of Medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
  • Department of Paediatrics, School of Medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan.

ORCID-Profile: Takeo Abe

Förderung

  • Chugai Pharmaceutical Co., Ltd

Zitieren

APA

Abe, T., Inagaki, Y., Ogita, C., Minagawa, Y., Tokugawa, T., Sawada, A., Higasa, S., Ohtsuka, Y., Hashimoto, T., & Azuma, N. (2026). Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross‐Sectional Study of Patient‐ and Joint‐Level Analyses Using Musculoskeletal Ultrasound. Haemophilia. https://doi.org/10.1111/hae.70345

Vancouver

Abe T, Inagaki Y, Ogita C, Minagawa Y, Tokugawa T, Sawada A, et al. Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross‐Sectional Study of Patient‐ and Joint‐Level Analyses Using Musculoskeletal Ultrasound. Haemophilia. 2026. doi:10.1111/hae.70345

BibTeX
@article{Abe2026,
  author = {Abe, Takeo and Inagaki, Yusuke and Ogita, Chie and Minagawa, Yuko and Tokugawa, Taduko and Sawada, Akihiro and Higasa, Satoshi and Ohtsuka, Yoshitoshi and Hashimoto, Teppei and Azuma, Naoto},
  title = {Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross‐Sectional Study of Patient‐ and Joint‐Level Analyses Using Musculoskeletal Ultrasound},
  journal = {Haemophilia},
  year = {2026},
  doi = {10.1111/hae.70345}
}
Kostenlos starten →